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ABSTRACT
ERAL1, a homologue of Era protein in Escherichia
coli, is a member of conserved GTP-binding proteins
with RNA-binding activity. Depletion of prokaryotic
Era inhibits cell division without affecting chromo-
some segregation. Previously, we isolated ERAL1
protein as one of proteins which were associated
with mitochondrial transcription factor A by using
immunoprecipitation. In this study, we analysed
the localization and function of ERAL1 in mamma-
lian cells. ERAL1 was localized in mitochondrial
matrix and associated with mitoribosomal proteins
including the 12S rRNA. siRNA knockdown of ERAL1
decreased mitochondrial translation, caused redis-
tribution of ribosomal small subunits and reduced
12S rRNA. The knockdown of ERAL1 in human
HeLa cells elevated mitochondrial superoxide pro-
duction and slightly decreased mitochondrial
membrane potential. The knockdown inhibited the
growth of HeLa cells with an accumulation of apop-
totic cells. These results suggest that ERAL1 is
localized in a small subunit of the mitochondrial
ribosome, plays an important role in the small ribo-
somal constitution, and is also involved in cell
viability.
INTRODUCTION
The circular 16.5kb human mitochondrial DNA
(mtDNA) molecule encodes 2 rRNAs, 22 tRNAs and 13
proteins of the mitochondrial oxidative phosphorylation
system responsible for the production of cellular ATP. All
the 13 proteins are considered to be essential subunits of a
mitochondrial respiratory chain. The 2 rRNAs and 22
tRNAs, used for constructing mitochondrial translational
machineries, are also essential for synthesis of the proteins
encoded by mtDNA (1,2). Given that majority of ATP
production depends on the respiratory chain, maintenance
of the mitochondrial genome is critical for individuals to
maintain normal health. The mitochondrial respiratory
chain consists of ﬁve complexes, composed of more than
80 structural proteins. The 13 mtDNA-encoded polypep-
tides are integral parts of four mitochondrial respiratory
chain complexes (I, III, IV and V). Complex II is an only
respiratory chain complex that lacks mtDNA-encoded
subunits (3).
Synthesis of these 13 proteins is carried out on a
specialized translational apparatus located in the mito-
chondrial matrix. Components of the mitochondrial trans-
lational machinery (translational factors, elongation
factor and mitoribosomes) are considered to generally
resemble the bacterial translational machinery and are
distinct from those in cytosol (4,5). Mitoribosome in
mammalian is a 55S particle composed of a small 28S
and a large 39S subunit and contains a much higher
number of proteins and RNAs than those of the bacterial
70S ribosome (6). All of  80 mitochondrial ribosomal
proteins are the products of nuclear genes and are
imported into the mitochondrial matrix (7). To assemble
the mitochondrial ribosome, the rRNA synthesis by the
mitochondrial transcription machinery needs to coordin-
ate with nuclear expression of the mitoribosomal proteins
(6). Several mutations are reported in the nuclear-encoded
translation machinery factors such as elongation factor
EFG1 and mitochondrial small ribosomal protein
(MRPS16 and MRPS22) of patients with autosomal re-
cessive mitochondrial translation defects (8–11).
Mammalian cells contain up to thousands of copies of
mtDNA. mtDNAs are organized in nucleoids (12,13).
Mitochondrial transcription factor A (TFAM), which
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known to be essential for the maintenance of mtDNA.
mtDNA molecules are packaged into nucleoids. TFAM
may be a main factor for the packaging (15). The
nucleoids may dynamically change their structure and dis-
tribution within mitochondria undergoing ﬁssion and
fusion and are involved in a variety of dynamic processes
including mitochondrial replication, transcription and
translation (16). Previously, we isolated ERAL1 as a
protein associated with TFAM (17).
In Escherichia coli, Era (E. coli Ras-like protein), is an
essential GTP-binding protein and exchanges guanine nu-
cleotide rapidly within seconds (18,19). Era leads to accu-
mulation of an unprocessed precursor of the 16S rRNA. It
is shown by electron microscopy that Era locates to the
cleft between the head and the platform of the 30S small
ribosomal subunit. Furthermore, Era makes contacts with
the several assembly elements of the 30S small ribosomal
subunit. These observations suggest direct involvement of
Era in the functional assembly of the 30S small ribosomal
subunit of E. coli (20).
In eukaryote, depletion and mutation of ERA, a
chicken homologue of Era, in chicken DT40 cells led to
growth impairment, accompanied by an accumulation of
apoptotic cells (21,22), suggesting that ERA also plays an
essential role in eukaryotic cells. The chicken ERA protein
regulates the G1 phase progression via an as yet unknown
molecular mechanism, in which an RNA recognition
domain of ERA protein was shown to be important.
However, there are no investigations on its subcellular
localization and function at mitochondria in DT40 cells.
We have previously found that ERAL1, a human
orthologue of ERA, is associated with mitochondrial
TFAM protein (17). ERAL1 has a putative N-terminal
mitochondria targeting sequence of 59 amino acids.
Here, we ﬁrst show that ERAL1 is localized in the mito-
chondrial matrix. Then, we sought to ﬁgure out the roles
of human ERAL1 in mitochondrial functions. We have
examined what mitochondrial components are associated
with ERAL1 protein. To know the physiological roles of
ERAL1 in mitochondria, we have investigated the mito-
chondrial functions such as mitochondrial membrane
potential and reactive oxygen species (ROSs) production
after siRNA-mediated knockdown of ERAL1.
Furthermore, we provide evidence that ERAL1 is
required for proper assembly of mitochondrial ribosomal
subunits and thus important for mitochondrial transla-
tion. Interestingly, the siRNA knockdown of ERAL1
led to cell growth retardation. These results suggest that
mitochondrial ribosome-associated ERAL1 plays an im-
portant role in mitochondrial function as well as viability
of human cells.
METHODS
Antibody
Anti-hemagglutinin (Anti-HA), TFAM, endonuclease G
(EndoG), mitochondrial single-stranded binding protein
(mtSSB), leucin rich protein 130 (LRP130), elongation
factor-Tu (EF-Tu), ERAL1 were raised in our own
laboratory. Anti-Calnexin, Histon H1, BAP37 were
purchased from StressGen (AnnArber, MI, USA),
Millipore (Millerica, MA, USA) and SantaCruze
(SantaCruze, CA, USA), respectively. MitoTracker Red
and H2DCFDA were purchased from Invitrogen
(Carlsbad, CA, USA).
Cell culture
Human cervical cancer HeLa cells were cultured in
Dulbecco Eagle’s minimal essential medium (Sigma, St
Louis, MO, USA) with 10% heat-inactivated fetal
bovine serum (FBS). Cell lines were maintained in a 5%
CO2 atmosphere at 37 C. In some experiments,
glucose-free Dulbecco’s modiﬁed eagle medium was
supplemented with 0.9mg/ml galactose, 1mM sodium
pyruvate, 10% FBS and 2mM L-glutamine.
Immunoﬂuorescent imaging of HeLa cells
Human HeLa cells were incubated in the presence of
100nM MitoTracker Red for 20min. After washing with
phosphate-buﬀered saline (PBS) three times, the cells were
ﬁxed with 3.7% formaldehyde for 30min, then incubated
with PBS containing 0.1% Triton X-100 for 30min. After
washing with PBS three times, the ﬁxed cells were blocked
with PBS containing 1% bovine serum albumin (BSA) for
30min. Then the cells were incubated with 250-fold diluted
anti-HA or -TFAM antibody in PBS/BSA for 1h. After
washing the cells with wash buﬀer (PBS containing
0.1% Tween-20) three times, the cells were incubated
with 250-fold diluted Alexa Fluor 488 goat anti-rabbit
IgG (Invitrogen) for 30min. The glass slides were
mounted using Slowfade mounting medium (Invitrogen).
Fluorescence images were obtained under a confocal laser
microscope (Nikon, Tokyo, Japan).
Immunoblot analysis
HeLa cells were lysed with Lysis buﬀer (50mM Tris–HCl,
pH 7.5, 1mM EDTA, 150mM NaCl and 0.5% NP-40)
(TNE) and total lysate (20mg) were subjected to
immunoblot analysis as described previously (23) using
polyclonal antibodies or monoclonal antibodies against
COX II (Invitrogen), caspase 3, cleaved caspase 3 (Cell
signaling, Danvers, MA, USA) and death associated
protein 3 (DAP3) (SantaCruz).
Proteins (20mg) were separated by SDS–polyacrylamide
gel electrophoresis (SDS–PAGE) and immunoblotted with
indicated speciﬁc antibodies. The signals were visualized
with horseradish peroxidase-labelled anti-rabbit immuno-
globulin G and an ECL reagent (GE healthcare). The
chemiluminescence was recorded and quantiﬁed with a
chilled charge-coupled device camera, LAS1000plus (Fuji
Photo Film, Tokyo, Japan).
Knockdown analysis using siRNAs
The following double-stranded ERAL1 RNA 25bp oligo-
nucleotides were generated from Stealth Select RNAi
(Invitrogen): 50-UAACCAUAGCAACAGAGUGCGUU
CC-30 and 50-GGAACGCACUCUGUUGCUAUGGUU
A-30. siRNA transfections were performed according to
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Oligofectamine (Invitrogen) was diluted in 100ml
Opti-MEM I medium (Invitrogen) and incubated for
5min at room temperature. Next, 20pmol ERAL1 or
control duplex Stealth RNA (Invitrogen) in 100ml
Opti-MEM I were added gently and incubated for 20min
at room temperature. Oligomer-Oligofectactamine
complexes and aliquots of 2 10
5 HeLa cells in 2ml
culture medium were combined and incubated for 10min
at room temperature. The cells were seeded in six-well
dishes with 2ml culture medium and assayed at indicated
time for western blotting and FACS analysis.
Cell proliferation assay
To determine cell proliferation, HeLa cells transfected
with control- or ERAL1-siRNA were seeded in 24-well
plates at a density of 2 10
4 cells per well. After 24h,
one set of cells was trypsinized, resuspended in PBS and
counted by a cell counter (Beckman Coulter, Fullerton,
CA, USA) (24). Cells were counted in a similar way
every 24h, up to 96h.
Expression of ERAL1 in HeLa Tet-on cells
cDNA of ERAL1 containing the deduced ﬁrst methionine
site was ampliﬁed from a cDNA library of human HeLa
cells by polymerase chain reaction (PCR) using a primer
set: 50-AT GGC TGC CCC CAG CTG GCG and 50-TCA
CTT GAG GAG CTT CAC AGA GAG. Then BamHI
and SpeI sites were added to the 50- and 30-terminals, re-
spectively, of the cDNA by a second PCR using primers,
50-ATA TGG ATC CAT GGC TGC CCC CAG CTG
GCG and 50-ATATACTAGT CTT GAG GAG CTT
CAC AGA GAG. The PCR product was digested
with BamHI and SpeI. The DNA fragment encoding
ERAL1, a DNA fragment encoding an HA-tag, and a
pcDNA5/FRT vector (Invitrogen) were digested with
BamHI and NheI and then were ligated. The vector was
named pERAL1-HA. We transfected HeLa/FRP/Tet-on
cells with the pERAL1-HA vector and selected cells
bearing the transgene in the presence of hygromycin B
(200mg/ml) as previously described (25).
Submitochondrial localization
HeLa cells (1 10
8 cells) cultured in 10-cm dishes were
scraped oﬀ with a cell lifter, suspended in PBS, precipitated
by centrifugation and washed with homogenizing buﬀer
(10mM HEPES-KOH, pH 7.4, 0.25M sucrose and
1mM EDTA). The cells were then suspended in four
volumes of the same buﬀer, homogenized with a
Potter-Elvehjem homogenizer, and centrifuged at 900g
for 10min. The supernatant was centrifuged at 10000g
for 6min. The pellet was collected as a crude mitochondrial
fraction. The crude mitochondria (20mg) were suspended
in hypotonic buﬀer (10mM HEPES-KOH, pH 7.4 and
1mM EDTA) at 4 C for disruption of the mitochondrial
outer membranes. After the hypotonic treatment, the
mitochondria were precipitated by centrifugation at
10000g for 6min. The mitochondria were resuspended in
hypotonic buﬀer and then digested with proteinase K
(200mg/ml) with or without 1% Triton X-100 on ice for
20min. The protein was precipitated by the addition of
15% trichloroacetic acid. The precipitates were solubilized
in sample buﬀer (6% SDS, 150mM Tris base, 10mM
EDTA and 25% glycerol), separated by SDS–PAGE,
and analysed by immunoblotting.
Immunoprecipitation using anti-HA antibodies
Each step was done at 4 C or on ice. Doxycyclin-induced
HeLa (ERAL1-HA) cells (1 10
8 cells) were homogenized
with a Potter-Elvehjem homogenizer in 2ml of
homogenizing buﬀer (10mM HEPES-KOH, pH 7.4,
0.25M sucrose and 1mM EDTA) and centrifuged at
900g for 10min. The supernatant ( 2ml) was diluted
with 2ml of 20% Percoll buﬀer [0.25M sucrose, 20mM
Tris-HCl, pH 7.4, 1mM EDTA and 20% Percoll
(GE healthcare)], and the sample was overlaid on a dis-
continuous Percoll density gradient (4ml of 40% and 4ml
of 20% Percoll buﬀer) in a 12-ml centrifugation tube.
After centrifugation at 24000r.p.m. for 1h using a
SW41Ti rotor (Beckman Coulter), a mitochondrial band
located in the middle of the tube was taken. Two to three
milligrams of mitochondrial protein were solubilized in
1ml of IP buﬀer (10mM Tris–HCl, pH 7.4, 150mM
NaCl, 1mM EDTA, 0.5% BSA and 0.5% NP-40) con-
taining 40ml of beads coated with anti-HA antibodies and
control mouse IgG. After 12h rotation, the beads were
washed four times with wash buﬀer (IP buﬀer without
BSA) and eluted with 1M glycine (pH 2).
Immunoprecipitation after crosslinking
All procedures were done at 4 C or on ice. Two milligrams
of mitochondrial protein were suspended in 1ml of
crosslinking buﬀer (0.25M sucrose, 20mM HEPES–
KOH, pH 7.4, 2mM EDTA and 25mM NaCl). Then
27ml of 37% formaldehyde or distilled water (as a
control) were added and the mixture was kept on ice for
2h. After incubation, 125ml of 1M glycine was added to
quench the crosslinking reaction, and the sample was
centrifuged at 10000g for 1min to precipitate the
mitochondria. The mitochondria were solubilized with
100ml of IP buﬀer containing 1% SDS. After 10-fold
dilution with 1ml of IP buﬀer, the immunoprecipitation
reaction was done as described above. The immunopre-
cipitates were heated at 95 C for 30min to cleave the
crosslinks and the proteins were separated by 12% SDS–
PAGE. Bands were visualized by staining with Coomassie
Brilliant Blue (CBB). The immunoprecipitates were
separated by SDS–PAGE and immunoblotted with each
antibody.
In-gel protein digestion and LC-MS/MS
A CBB-stained band was excised and the protein was
digested with Lysyl Endopeptidase (WAKO, Japan) in di-
gestion buﬀer (100mM Tris–HCl, pH 9.0, 0.5% SDS and
1mM EDTA) for 12h. The supernatant containing the
digested peptides was analysed by liquid chromatography
and mass spectrometry (LC/MS/MS) (Agilent 1100 Series
an LC/MS system). The peptide masses were assigned to
the peptide mass databases using the MASCOT program
(MATRIX SCIENCE). All proteins in the SWISS-PROT
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peptide mass error was limited to 1.0Da and the
MS/MS mass error was limited to 0.8Da. Only one
missed cleavage was accepted.
Analysis of ROS production
The intracellular H2O2 concentration was estimated by
means of an oxidation-sensitive ﬂuorescent probe dye,
2070-dichlorodihydroﬂuorescein diacetate (H2DCFDA)
(Invitrogen). H2DCFDA was deacetylated intracellularly
by non-speciﬁc esterase, which was further oxidized by
cellular peroxides to the ﬂuorescent compound,
2,7-dichloroﬂuorescein (DCF). In brief, cells were
incubated with the ERAL1- or control siRNA for 72h.
The cells were then washed in PBS and incubated with
20mMH 2DCFDA at 37 C for 30min according to the
instructions of the manufacturer. DCF ﬂuorescence was
detected using a ﬂuorescence activated cell sorting (FACS)
caliber ﬂow cytometry (Becton Dickinson, Flanklin
Lakes, NJ, USA). For each sample, 10000 events were
collected. H2O2 production was expressed as mean ﬂuor-
escence intensity, which was calculated by FlowJo
software.
Pulse-labelling of mitochondrial translation products
In vitro pulse-labelling of mitochondrial translation with
[
35S]-(methionine and cysteine) (GE Healthcare) for 1h
was performed. In experiments where the label was
chased, cells were incubated for 6min in emetine
(100mg/ml) prior to labelling. The labelled cells were
rinsed with isotonic buﬀer (25mM Tris–HCl, pH 7.4,
137mM NaCl, 10mM KCl, 0.7mM Na2HPO4). After
centrifuge 115g for 5min, the pellets were suspended in
loading buﬀer containing 93mM Tris–HCl, pH 6.7,
7.5% glyrerol, 1% SDS, 0.25mg/ml of bromophenol
blue and 3% mercaptoethanol. And the total lysate
(50mg) was loaded and run on 14% SDS–PAGE for 3h
at 180V. The gels were ﬁxed in a methanol–acetic acid
solution, treated with Amplify and measured by
BAS2500 (Fuji).
Sucrose gradient analysis of mitochondrial ribosomes
Cell lysates were prepared from HeLa cells treated with
ERAL1 or non-targeted (Control) siRNA for 72h. The
HeLa cells were solubilized in a non-ionic detergent
(1% lauryl maltoside). Total cell lysates (2mg) were
loaded on a 10–35% sucrose density gradient in 10mM
Tris–HCl, pH 7.2, 150mM NaCl, 1mM EDTA and
centrifuged for 3h at 100000g at 4 C by using a
swinging bucket SW 40.1 rotor (Beckman Coulter).
After separation through 10–35% sucrose gradients, frac-
tions were precipitated by 10% trichloroacetic acid and
washed in acetone, and the entire fraction was resolved
by SDS–PAGE. The small (Elongation Factor-Tu(EF-
Tu) DAP3, MRPS22) and large (MRPL3) mitochondrial
ribosomal subunits, ERAL1, cytochrome c oxidase (COX)
II, TFAM, Lon and LRP130 were detected by immuno-
blotting. For real time PCR, RNA was extracted from
50ml of fractions and was assayed by real time PCR.
To co-immunoprecipitate RNA with ERAL1-HA protein
We used a previously described procedure (24). Brieﬂy,
HeLa mitochondria lysates induced by doxycycline were
ﬁrst pre-cleared with 50mg of rabbit IgG (Bio-Rad) by
bath-sonicating for 15min at 4 C, followed by binding
to anti-HA agarose beads and control IgG for 12h at
4 C. The complexes were pulled down and washed four
times with 1ml of immunoprecipitation buﬀer. Then,
RNA was eluted from the beads with a QIAGEN
RNAeasy kit (QIAGEN, Hilden, Germany). Two micro-
grams of the eluted mitochondrial RNA (mtRNA) were
treated by DNase I (100 units) at 37 C for 30min and then
the mtRNA was cleaned with an RNAeasy kit. The RNA
pellets were resuspended in water and stored at  70 C.
Quantiﬁcation of mRNAs
Total RNA was extracted from HeLa cells or a fraction of
sucrose density gradient with a QIAGEN RNAeasy kit
(QIAGEN). Two micrograms of RNA were treated by
DNase I (100U) at 37 C for 30min and then RNA was
cleaned with an RNAeasy kit. The reverse transcription
(RT) of 1mg of the total RNA was performed with
SuperScript II RT (Invitrogen) according to manufactur-
er’s instructions. Random 6-mer primers were used in the
RT reaction. The expressions of mitochondrial genes were
detected by quantitative PCR with a thermal cycler
(StepOne plus, Invitogen). The PCR primers were listed
in Supplementary Table S1.
RT-PCR
RT reactions were carried out using SuperScript II RT
and random primers in a 20:1 volume following the
manufacturer’s protocol. RT reaction mixtures were
diluted 1:10 with water and the cDNAs were used for
PCR. Primer pairs were shown in supplementary Data.
RESULTS
ERAL1 in mitochondria
ERAL1 is a protein composed of 368 amino acids as
deduced from its cDNA. The existence of a 59-amino
acid N-terminal mitochondria targeting sequence was pre-
dicted by MitoProt II, a prediction program for mitochon-
drial localization. The probability of mitochondrial
localization is 0.9998 for ERAL1. Then, we produced
stable cell lines that express the recombinant full length
ERAL1 with a C-terminal HA tag (ERAL1-HA) upon
induction by doxycycline addition. The recombinant
ERAL1-HA was seen only after the induction by
doxycycline-addition at 24 and 48h (Figure 1A). In im-
munocytochemistry, the ERAL1-HA was granularly
stained with anti-HA antibodies after the induction
(Figure 1B). The HA-staining is completely co-localized
with the mitochondria visualized with a MitoTracker
Red dye, suggesting that the expressed ERAL1 is exclu-
sively localized at mitochondria.
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Then we examined the intracellular localization of ERAL1
by cellular fractionation. The HeLa cells were separated
into Nuclear (Nu), Mitochondrial (Mt), microsomal
(Micro) and cytosolic (Cyt) fractions. Calnexin,
histoneH1, mtSSB and TFAM were detected by immuno-
blotting as markers for endoplasmic reticulum, nuclei,
mitochondria and mitochondria, respectively. The mito-
chondrial fraction contained essentially no histoneH1,
a nuclear protein, indicating minimal contamination of
the mitochondrial fraction by nuclei (Supplementary
Figure S1). ERAL1-HA was found mostly in the mito-
chondrial fraction as were TFAM and mtSSB
(Supplementary Figure S1, third lane). TFAM was also
very weakly detected in the nuclear fraction. Calnexin was
detected in the microsomal fraction. These results suggest
again that ERAL1 is localized at mitochondria.
Submitochondrial localization of ERAL1
Next we examined the submitochondrial localization
of ERAL1-HA. The mitochondrial outer membranes
were disrupted by hypotonic treatment (Figure 2, lanes 3
and 4) as veriﬁed by the observation that EndoG is
localized in the intermembrane space (IMS), was com-
pletely digested by proteinase K (Figure2, lane 4).
BAP37, which is an inner membrane (IM) protein and
largely faces the IMS, was digested by proteinase K. On
the other hand, TFAM, which localizes in the matrix, was
resistant to the proteinase K digestion (Figure 2, lane 4 in
lower panel), indicating that the IMs were intact. Under
these hypotonic conditions, ERAL1 was not cleaved by
proteinase K (Figure 2, lane 4 in upper panel). When the
IMs were solubilized with a non-ionic detergent Triton
Ab: ERAL1 HA
(-) (-) 24 24 48 48 (hr)
*
*
47kD
68kD
38kD
123 456
Anti –HA 
Mitotracker
Red
Merge
A
B
Figure 1. Inducible expression of recombinant ERAL1 with an
HA tag. (A) ERAL1 with an HA tag was inducibly expressed in
HeLa cells using a Tet-on system as described under ‘Methods’
section. ERAL1 was detected by immunoblotting with anti-
ERAL1 (lanes 1–3) and anti-HA (lanes 4–6) antibodies. Lanes 1/4;
no induction, lanes 2/5 and 3/6; 24 and 48h after tetracycline treat-
ment, respectively. Arrows and an arrowhead indicate recombinant
and endogenous ERAL1, respectively. Asterisks show non-speciﬁc
bands. (B) Immunocytochemistry of recombinant ERAL1. The
ERAL1-HA-transfected cells were cultured in the presence of
doxycyclin for 48h. Mitochondria and the recombinant ERAL1 were
visualized with a mitochondria-staining dye, MitoTracker Red, (middle
panels) and anti-HA antibodies (upper panel), respectively. The lower
panels are merged.
BAP37
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TFAM
(Matrix)
EndoG
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Figure 2. Submitochondrial localization of exogenous ERAL1-HA.
Mitochondria were incubated in hypotonic buﬀer for disruption of
the outer membranes without (lanes 3 and 4) or with a non-ionic de-
tergent, Triton X-100 (lane 5). Then the mitochondria were digested
with proteinase K (lanes 2, 4 and 5). The indicated proteins were
detected by immunoblotting. EndoG, BAP37 and TFAM are markers
for the mitochondrial IMS, IM and matrix, respectively.
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ase K (Figure 2, lane 5). Taken together, these results
suggest that ERAL1 is localized in the mitochondrial
matrix side of IM.
RNA immunoprecipitation
Escherichia coli Era protein has the KH domain which can
bind to RNA. We performed RNA immunoprecipitation
assay to test whether ERAL1 protein associates with mito-
chondrial ribosome including the mitochondrial ribosome
RNA or mitochondrial transcripts in vivo. Mitochondrial
lysates were prepared using immunoprecipitation buﬀer.
After immunoprecipitation with anti-HA antibodies,
RNA was extracted from the immunoprecipitates and
the eluted mtRNA was used as a template in the RT
reaction (Figure 3A). As a control, total mtRNA was
used in the RT reaction (Figure 3A, lane 5). First,
primer pairs covering 12S rRNA were used in the PCR.
A PCR product with a predicted size was obtained for
12S mitochondrial rRNA from the mtRNA (Figure 3A,
lane5) and the mtRNA obtained from the HA-
immunoprecipitates (Figure 3A, lane 4). There were no
PCR products irrespective of the RT reaction when the
template was obtained by immunoprecipitation with
control IgG (Figure 3A, lanes 1 and 2). There were also
no PCR products without RT from the
HA-immunoprecipitates (Figure 3A, lane 3), indicating
no DNA contamination. Next we investigated whether
ERAL1 protein was associated with the other mitochon-
drial transcripts. We examined 16 PCR primer sets for
mitochondrial genes. Only 12S ribosomal RNA was
PCR-ampliﬁed (Figure 3B). These results suggest that
ERAL1 is associated with the mitochondrial ribosomal
small subunit which contained 12S mitochondrial riboso-
mal RNA or directly associated with 12S rRNA. The
latter is likely based on its homology to bacterial Era
and chicken ERA.
Proteins associated with ERAL1
To seek for proteins interacting with ERAL1 in
mitochondria, we immunoprecipitated ERAL1-HA-
associated proteins with anti-HA antibodies after cross-
linking reactions (Figure 4, upper panel). Under these con-
ditions, DAP3 (mitochondrial ribosome protein S29),
LRP130 and EF-Tu (mitochondrial translation elong-
ation factor) were detected in the immunoprecipitates
12S rRNA
7. COXII
8. ATP8
9. ATP6
10. COXIII
11. ND3
12. ND4L
13. ND4
14. ND5
15. ND6
16. Cyt B
1. D-loop
2. 12S rRNA
3. 16S rRNA
4. ND1
5. ND2
6. COX1
IP-
RT
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11 10 9 8 7 6 5 4 3 2 1 1 21 31 41 51 6
1234567
RT
A
B
-+     -+ + - -
IP IgG HA
m
t
R
N
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n
o
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N
A
Figure 3. ERAL1 is associated with mitochondrial 12S rRNA in HeLa cells. (A) ERAL1-HA-transfected HeLa cells were treated by tetracycline for
48h. The cells were lysed by TNE buﬀer and immunoprecipitated with control IgG (lanes 1 and 2) or anti-HA antibodies (lanes 3 and 4). RNAs were
extracted using an RNAeasy kit from the immunoprecipitates (lanes 1–4) and whole cells (lanes 5 and 6) and then treated with DNaseI. The
DNaseI-treated RNAs were subjected to RT (lanes 2, 4 and 5) or not subjected to RT (lanes 1, 3 and 6) and then ampliﬁed by PCR with a primer set
for 12S rRNA. No RNA template in lane 7. (B) The RNA in lane 4 of (A) (IP-RT, upper panel) and that in lane 5 of (A) (RT, lower panel) were
ampliﬁed similarly by PCR using indicated primer sets for 16 mitochondrial genes.
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mitoribosome or translation related machinery. We also
detected TFAM in the immunoprecipitates.
The other cross-linked proteins which were found by
LC-MS/MS analysis are listed in Table 1. The
LC-MS/MS analysis revealed three mitoribosomal
proteins, presumably indicating the presence of ERAL1
in the small (28S) ribosomal subunits. The second group
was proteins which were reported to be associated with
human mitochondrial nucleoids. There were factors
involved in intra-organellar translation, nucleic acid
binding proteins and chaperones/proteases, all of which
are expected to associate with ribosomal components or
nascent peptides. Several polypeptides known to be
involved in metabolism were also identiﬁed. In
non-cross-linked experiments, we observed that
ERAL1 was associated with two tRNA synthetase and
Stress70 protein. In summary, many proteins related to
chaperons and translation machinery were identiﬁed by
LC-MS/MS.
siRNA-mediated knockdown of ERAL1 induced
mitochondrial dysfunction
To identify the ERAL1 function in mitochondria matrix,
we used an siRNA strategy to downregulate the ERAL1
expression. Because ERAL1 localized in mitochondrial
matrix and associated with mitochondrial ribosomes, we
hypothesized that suppression of the ERAL1 expression
could have animpact onmitochondrial function, especially
translation. The expression of ERAL1 was diminished by
ERAL1-targeted siRNA treatment for 72h. However,
DAP3, cytochrome c and TFAM were not aﬀected by
the ERAL1 knockdown for 72h (Figure 5A). A
non-targeting siRNA (control siRNA) was used to
conﬁrm speciﬁcity.
Reduced translation rate in vivo labelling
To investigate the defect in mitochondrial protein synthe-
sis caused by the ERAL1 siRNA transfection, HeLa cells
were pulse-labelled with a mixture of [
35S] methionine and
[
35S] cystein in the presence of emetine, an inhibitor of
cytoplasmic translation. The overall rate of protein syn-
thesis in mitochondria of the ERAL1 siRNA transfectants
was  50% of the control siRNA transfectants as shown in
Figure 5B. Especially, the protein synthesis rate of COX I,
II and III seemed more strongly decreased than the other
proteins when ERAL1 was downregulated. These results
suggest that ERAL1 protein is involved in mitochondrial
translation.
Depletion of ERAL1 decreased COX II protein
To verify the selective eﬀects on the protein synthesis by
the ERAL1 knockdown, HeLa cells were transfected with
the ERAL1 siRNA and the changes of several proteins
were analysed by western blotting. ERAL1 protein was
decreased by 24h after the ERAL1 siRNA transfection.
mtSSB was not altered up to 96h (Figure 5C). Consistent
with the stronger decrease of the COX II translation
(Figure 5B), a COX II protein level was decreased at
48h after the siRNA transfection (Figure 5C).
Next, to see if the overall decrease of the mitochondrial
translation was aﬀected by the amounts of mRNAs, we
investigated eﬀects of the ERAL1 depletion on expression
of the mitochondrially encoded RNAs. The ERAL1-
directed siRNA signiﬁcantly lowered the mRNA levels
of 12S rRNA, COX I, COX II and ND5 (Figure 5D),
but at most moderately aﬀected the 16S rRNA, ND1,
ND2, ND3, ND4, cyt b and ND4L transcripts. This rela-
tively stronger decrease of COX II mRNA might contrib-
ute in part to the apparent stronger decrease of the COX
II translation. The decrease of 12S rRNA might be caused
by disassembly of the mitoribosomes as shown later
(Figure 6A). It is currently unknown how the other
mRNAs was decreased by the ERAL1 depletion.
Depletion of ERAL1 aﬀects mitochondrial small subunit
The ERAL1 siRNA inhibited the mitochondrial protein
synthesis. To further clarify a role of ERAL1 in the mito-
chondrial translation, we analysed sedimentation proﬁles
in a sucrose density gradient (Figure 6A). The 3-days
ERAL1
DAP3
LRP130
EF-Tu
Total Mitochondria 
IP - anti HA
IP - anti-IgG
mtSSB
*
TFAM
Figure 4. Mitochondrial proteins crosslinked to ERAL1-HA.
ERAL1-HA-transfected HeLa cells were treated by tetracycline for
48h. Mitochondrial fraction was puriﬁed by percoll density gradient
and lysed by TNE buﬀer. Immunoprecipitates obtained with anti-HA
and mouse-IgG were separated by SDS–PAGE and then
immunoblotted with anti-EF-Tu, ERAL1, LRP130, TFAM, mtSSB
and DAP3 antibodies. An asterisk indicates a heavy chain of IgG.
5560 Nucleic Acids Research, 2010,Vol.38, No. 16treatment with the ERAL1 siRNA signiﬁcantly decreased
ERAL1 in a HeLa cell (Figure 6A, panels 1 and 2) as well
as COX II (Figure 6A, panels 9 and 10) as expected. Either
the amounts or distribution proﬁles of the other proteins
were not changed by the ERAL1 depletion (Figure 6B).
Therefore, the same number of fraction may be compar-
able before and after the ERAL1 depletion.
ERAL1 largely co-migrated with the small ribosomal
subunit proteins (MRPS22 and DAP3) (Figure 6A,
panels 1, 3 and 5), suggesting that ERAL1 associates
with the small subunit of mitochondrial ribosome
(Figure 6A). The treatment caused a striking change in
the distribution of MRPS22, proteins of the small riboso-
mal subunits. In spite of the decrease of overall amount,
MRPS22 became evident also in fractions 11 and 12
(Figure 6A, compare panels 3 and 4). Thus, the ERAL1
siRNA treatment shifted the distribution of MRPS22 to
heavier fractions. These results suggested that ERAL1 is
required for proper assembly of mitochondrial ribosomal
small subunits. Conversely, MRPL3 protein were
distributed within fractions 9–11 (Figure 6A, panels 7
and 8) and the distribution of MRPL3 were barely
changed by the ERAL1 depletion. Taken together, we
consider that the ERAL1 associates with small ribosomal
subunit and ERAL1 depletion compromises assembly of
the small ribosomal subunit.
Next, we investigated the sedimentation proﬁle of 12S
rRNA (small subunit) and 16S rRNA (large subunit)
in the sucrose density gradient (Figure 6C and D).
Quantitative PCR analysis showed that the amount
of 12S rRNA at fraction 7–8 was decreased after
ERAL1 depletion. However, the abundance of 12S
rRNA at fractions 9–10 was not changed even after the
ERAL1 depletion (Figure 6C). The relative 12S rRNA
distribution is consistent with the results of MRPS22
protein (Figure 6A and C). The distribution and the
total amount of 16S rRNA were little changed even
after the ERAL1 depletion, suggesting that the ERAL1
depletion did not aﬀect the assembly of the large subunit
itself (Figure 6D). Taken together, we consider that the
ERAL1 depletion aﬀected assembly of the small riboso-
mal subunit.
ERAL1 siRNA-mediated knockdown reduced MMP
The ERAL1 siRNA-mediated inhibition of the mitochon-
drial translation may inﬂuence mitochondrial functions.
First, we measured mitochondrial membrane potential
(MMP) (cm) using JC-1 that is a ﬂuorescent dye sensi-
tive to mitochondrial membrane potential. The cm
value of ERAL1 siRNA transfectants was lower than
those of normal as well as control siRNA transfected
cells (Supplementary Figure S3). carbonyl cyanide
m-chlorophenylhydrazone (CCCP)-treated cells served as
a positive control for depolarization of the mitochondrial
membrane.
The lower mitochondrial membrane potential in the
ERAL1 siRNA-transfected cells was further conﬁrmed
by staining with MitoTracker Red, a ﬂuorescent dye
Table 1. List of proteins identiﬁed in complex with ERAL1
Swiss-Prot
accession number
Gene symbol Name No. of peptides
matched
% Sequence
coverage
MW PI Nucleoid
type
P38646 HSPA9 Stress-70 protein 8 17 73920 5.87 Class I
Q15031 LARS2 Leucyl-tRNA synthetase 4 4 102823 8.46
Q9BW92 TARS2 Threonyl-tRNA synthetase 1 1 81841 6.9
P31327 CPS1 Carbamoyl-phosphate synthase 8 4 165975 6.30 Class I
P42704 LRPPRC Leucine-rich PPR motif-containing protein 7 5 159003 5.81 Class I
Q00059 TFAM Transcription factor A 1 4 29306 9.74 Class I
P34897 SHMT2 Serine hydroxymethyltransferase 3 5 56414 8.76 Class I
P49411 TUFM Elongation factor Tu 3 8 49852 7.26 Class I
P10809 HSPD1 60kDa heat shock protein 24 37 61187 5.70 Class II
Q99623 PHB2 Prohibitin-2 7 24 33276 9.83 Class II
P40926 MDH2 Malate dehydrogenase 2 7 35965 8.92 Class III
P54886 ALDH18A1 Delta-1-pyrroline-5-carboxylate synthetase 3 3 87989 6.66
Q12931 TRAP1 Heat shock protein 75kDa 3 4 80345 8.30
P31040 SDHA Succinate dehydrogenase [ubiquinone]
ﬂavoprotein subunit
1 2 73672 7.06
Q5R1W8 VIM Vimentin 6 17 53677 5.03
P00367 GLUD1 Glutamate dehydrogenase 1 6 12 61701 7.66
P55084 HADHB Trifunctional enzyme subunit g 1 2 51547 9.45
O75616 ERAL1 GTP-binding protein era homologue 20 32 48833 9.05
P60709 ACTB Actin, cytoplasmic 1 5 15 42052 5.29
P82650 MRPS22 28S ribosomal protein S22 1 3 41425 7.70
P04406 GAPDH Glyceraldehyde-3-phosphate dehydrogenase 3 12 36201 8.57
P48047 ATP5O ATP synthase subunit O 4 24 23377 9.97
Q9UIK4 DAPK2 Death-associated protein kinase 2 2 4 43042 6.45
Q92665 MRPS31 28S ribosomal protein S31 2 6 45405 9.32
Q46199 MTIF2 Translation initiation factor IF-2 3 2 81837 6.71
P82909 MRPS36 28S ribosomal protein S36 1 4 11459 9.99
The columns correspond to their accession number, gene symbol, name, number of unique peptide matched, percent sequence coverage, estimated
MW and PI identiﬁed by LC-MS/MS analysis. We observed top three proteins in non-crosslinkng condition. Putative nucleoid proteins as recently
classiﬁed by Bogenhagen et al. (29). Class I: core nucleoid protein, Class II: proteins seen in native but not cross-linked nucleoids and Class III:
proteins seen in cross-linked but not native nucleoids.
Nucleic Acids Research, 2010,Vol.38, No. 16 5561accumulating in mitochondria depending on the mito-
chondrial membrane potential. HeLa cells were trans-
fected with control and ERAL1 siRNAs for 72h. The
cells pre-treated with MitoTracker Red for 20min were
ﬁxed and then TFAM was stained with anti-TFAM
antibodies (Supplementary Figure S4). The ﬂuorescence
intensity or pattern of TFAM staining was not changed
(upper panel), however the ERAL1 siRNA-mediated
knockdown cell were signiﬁcantly weakly stained with
MitoTracker Red (center and lower panels, right), sug-
gesting that the ERAL1 depletion reduced the mitochon-
drial membrane potential.
Depletion of ERAL1 increases mitochondrial ROS
Stress conditions in mitochondria are frequently
associated with elevated levels of ROS. A tight link
exists between mitochondrial ROS generation and
ERAL1
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Figure 5. siRNA-mediated knockdown of ERAL1 and in vivo labelling. (A) HeLa cells were transfected with nothing (lane 1), control siRNA (lanes
2 and 6), and 5, 10, 20 pmol of ERAL1 siRNA (lanes 3–5) using oligofectamine. After 2 days of the transfection, the cells were lysed and followed by
immunoblotting with anti-ERAL1, cytochrome c, TFAM and DAP3 antibodies. (B) Synthesis of mitochondrial polypeptides. HeLa cells were
transfected with control and ERAL1 siRNAs for 72h. These cells were pulse-labelled in the presence of emetine. The mitochondrial translation
products were run on a 15–20% polyacrylamide gradient gel. The gel was processed for ﬂuorography as detailed in the ‘Methods’ section. The seven
complex I subunits (ND), one complex III subunit (cyt b), three complex IV subunits (COX) and two complex V subunits (ATP) are indicated on the
right. (C) siRNA-mediated knockdown of ERAL1. HeLa cells were transfected with ERAL1 siRNA and harvested every 24h. The cells were lysed
and followed by immunoblotting with anti-ERAL1, COX II and mtSSB antibodies. (D) Quantiﬁcation of mitochondria-encoded mRNA. HeLa cells
were treated with control or ERAL1 siRNA for 72h. The amounts of mRNAs were measured as described under ‘Methods’ section. The value in
control siRNA-treated cells is 100% for each mRNA.
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Figure 6. Reduction of ERAL1 results in redistribution of ribosomal protein and ribosomal RNA. (A and B) Cell lysates were prepared from HeLa
cells treated with ERAL1 or non-targeted (control) siRNA for 72h. After separation by centrifugation through 10–35% sucrose, the sample was
divided into 17 fractions. Each fraction was analysed by western blotting using antibodies against the small (DAP3, MRPS22) and large (MRPL3)
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Nucleic Acids Research, 2010,Vol.38, No. 16 5563collapse of mitochondrial membrane potential. In subse-
quent experiments, therefore, the production of oxidants
was tested by a redox-responsive ﬂuorescent dye
H2DCFDA to examine whether ERAL1 siRNA
knockdown led to the generation of ROS. A statistically
signiﬁcant increase in the ﬂuorescence over the control
was seen at 72h after the siRNA transfection (Figure 7).
Cell growth retardation
In order to investigate the eﬀect of the elimination of
ERAL1 on the cell growth, the number of living cells in
each clone was monitored using a cell counter (Figure 8A,
upper panel). Up to 2 days after siRNA transfection, there
was no signiﬁcant diﬀerence in the growth or morphology
of the cells between ERAL1 siRNA and control siRNA
transfectants. However, the increase in living cells was
markedly suppressed at Day 3 in ERAL1 siRNA-treated
cells and this was accompanied by an increment in the
population of round and dead cells. These results
indicate that ERAL1 is important for the normal cell pro-
liferation and its loss aﬀects mitochondrial functions. We
cultured the cells in glucose-free media instead supple-
mented with galactose to force dependence on oxidative
phosphorylation. Even in the galactose culture media, the
inhibitory eﬀect of ERAL1 depletion on the cell prolifer-
ation was little changed (Figure 8A, lower panel), raising
the possibility that the inhibition of the cell proliferation is
not much dependent on the mitochondrial dysfunction.
Induction of apoptosis in ERAL1 knockdown HeLa cells
The increase in the apparently apoptotic cells as described
earlier prompted us to conﬁrm apoptotic cell death by
examining caspase 3 activation. After the treatment of
ERAL1 siRNA for 72h, the cells were lysed and subjected
to western blotting. Cleaved caspase 3 or activation of
caspase 3 was observed in the ERAL1 knockdown cells
(Figure 8B).
DISCUSSION
Here we have shown that ERAL1 is a mitochondrial
ribosome-associated factor and is important for mito-
chondrial function and cell viability based on the follow-
ing evidence; (i) ERAL1 is a mitochondrial matrix protein,
(ii) ERAL1 is associated with small mitoribosomes
including the 12S rRNA, (iii) depletion of ERAL1
impairs the assembly of the small subunit of
mitoribosome, inhibits the mitochondrial translation, de-
creases mitochondrial membrane potential and increases
ROS generation and (iv) depletion of ERAL1 severely
retards cell growth. One of primary roles of ERAL1
may be in the formation of functional ribosomal small
subunits and might be involved in mitochondrial biogen-
esis and associated with the mitochondrial ribosome
during the assembly, rRNA folding and RNA
modiﬁcation.
A direct link between mitochondrial transcription and
translation has been demonstrated in Saccharomyces
cerevisiae. An amino-terminal domain of mitochondrial
RNA polymerase (Rpo41p) is a binding site for Nam1p
that is proposed to deliver newly synthesized RNAs to the
inner mitochondrial membrane and promote subsequent
interactions between gene speciﬁc translational activators
and ribosomes. Thus the processes of transcription and
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titative estimation of ROS.
5564 Nucleic Acids Research, 2010,Vol.38, No. 16translation are physically and functionally coupled in S.
cerevisiae (26,27).
Proteins co-immunoprecipitated with ERAL1 included
putative nucleoid proteins in addition to mitochondrial
ribosomal proteins and several translation-associated
proteins in HeLa cells (Table 1). Nucleoids are dynamic
structures containing mtDNA and proteins, which are
involved in maintenance, replication and transcription of
mtDNA (13). Coupling of transcription and translation in
human mitochondria has been suggested (3). There has
been reported interaction of mitochondrial RNA polymer-
ase with a mitoribosomal protein MRPL12. This inter-
action was shown in vitro to stimulate transcription (28).
In a recent report on proteins associated with mitochon-
drial nucleoids, 15 mitoribosomal proteins were identiﬁed
along with assorted factors that also function in protein
synthesis (29). These results raise the possibility that mito-
chondrial ribosomal proteins and associated factors are
coupled with transcription via transcription-related
factors such as TFAM also in higher eukaryotes.
Gohda et al. (21) reported that depletion of chicken
ERA protein diminished the growth rate of the cell,
accompanied by an accumulation of apoptosis cells. The
analysis of cell cycle indicates that the elimination of
chicken ERA caused arrest at G1 phase but not at M
phase, which suggests a distinct role of chicken ERA in
the cell cycle progression from that of bacterial Era
protein (21,22). They showed that chicken ERA protein
was localized in cytosol in DT40 cells and bound to RNA
homopolymer (poly-U). Our experiment showed that
human ERAL1 was localized at mitochondrial matrix
and associated directly or indirectly with 12S mitochon-
drial rRNA. Depletion of human ERAL1 also diminished
the growth rate of HeLa cell probably by apoptosis. In a
eukaryotic cell, ERAL1 may be involved in cell viability
and apoptosis at least in part through the mitochondrial
function.
The human mitochondrial ribosome recycling factor is
essential for cell viability (30). Rorbach et al. (30) cloned
the putative mitochondrial recycling factor, mtRRF and
showed that the protein could associate with
mitoribosomes. Depletion of mtRRF was lethal, causing
initially mitochondrial dysmorphism, aggregation of
mitoribosome, elevated mitochondrial ROS and loss of
OXPHOS complexes. The phenotypes caused by ERAL1
depletion resemble to those by mtRRF, suggesting that
ERAL1 and mtRRF share the some functions or cooper-
ate in mitochondrial ribosomes.
Mitochondrial nucleoids include not only factors
involved in replication and transcription but also struc-
tural proteins required for mtDNA maintenance.
Recently, Wang and Bogenhagen (31) reported that
EF-Tu, LRP130, ATAD3 and DHX30 were TFAM-
and mtSSB-associated proteins. EF-Tu is a translation
elongation factor with signiﬁcant homology to its pro-
karyote counterparts. Previously we have isolated several
proteins such as ERAL1, EF-Tu, LRP130 and Hsp60 by
co-immunoprecipitaion with TFAM (17). Thus, the
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in addition to transcription, replication and mtDNA
maintenance.
In E. coli RbfA (ribosome-binding factor A) is essential
for cell growth at low temperature (32,33). RbfA is a bac-
terial cold shock response protein, required for an eﬃcient
processing of the 50 end of the 16S ribosomal RNA during
assembly of the small (30S) ribosomal subunit. RbfA
binds to the 30S subunit in a position overlapping the
binding site of the A and P sites for tRNAs. RbfA has
an important role in maturation of the 30S subunit and is
involved in translational advantage under conditions of
cold shock. It is demonstrated that Era and RbfA have
an overlapping function that is essential for the ribosome
biogenesis (32). Mammalian ERAL1 is also likely to bind
12S rRNA, is associated with the small subunit of mito-
chondrial ribosome, and is involved in the ribosomal
assembly. Considering the importance of ERAL1 for
cell viability, it might be also involved in stress response
like RbfA.
Genetic investigation of patients with defective mito-
chondrial translation led to the discovery of novel muta-
tions in EFG1 in one aﬀected baby and in the
mitochondrial EF-Tu in another one (34). Both patients
were aﬀected by severe lactic acidosis and rapidly progres-
sive, fatal encephalopathy. The EFG1-mutant patient had
early-onset Leigh syndrome, whereas the EF-Tu mutant
patient had severe infantile macrocystic leukodystrophy
with micropolygyria. ERAL1 is a mitoribosomal protein
which is associated with a small subunit of ribosome. In
our immunoprecipitation analysis, we showed the inter-
action of ERAL1 with EF-Tu. ERAL1 might be
involved in the translation reaction itself in addition to
the assembly of mitoribosomes.
DAP3, which exists in the mitochondrial matrix, is
involved in apoptosis (35). DAP3 has been reported to
be involved in both g-interferon and tumour necrosis
factor-a-induced apoptosis as well as staurosporine-
induced mitochondrial fragmentation (36–38). hNOA1
(human nitric oxide-associated protein 1) interacts with
complex I and DAP3 and regulates mitochondrial respir-
ation and apoptosis (39). ERAL1 is also associated with
DAP3 and depletion of ERAL1 causes apoptosis.
Accordingly, ERAL1 could be involved in apoptosis
through the DAP3 interaction.
So far, DAP3 has been the only GTP-binding protein
found in the small subunit of the mammalian and yeast
mitochondrial ribosomes (40). This protein accounts for
the highly speciﬁc GTP-binding aﬃnity of small subunits
of mitochondrial ribosomes. An immuno-electron micro-
scopic study showed that DAP3 is localized to the base of
the lower lobe of the small subunit on the solvent side of
the ribosome (41). ERAL1 is associated with the small
ribosomal subunit and has a putative GTPase domain.
There is the possibility that ERAL1 and DAP3
coordinately regulate the mitochondrial translation and
apoptosis.
DAP3 is located at the lower bottom of the 28S subunit
and it is not likely that it would interact with a protein that
would bind to the platform of the small subunit. In our
experiment by using the sucrose density gradient
centrifugation, ERAL1 and DAP3 distributed broadly
also in lighter fractions through fractions 1–6. However
the distribution of other small subunit protein such as
MRPS22 and large subunit protein MRPL3 were
located through fractions 9–11. The RNA distribution
analysis also showed that the ribosomes were located to
fractions 7–9, raising the possibility that some DAP3
protein do not associate with the small ribosomal
subunits and conducts another function for example as a
death associated protein. We also observed that ERAL1
was associated with DAPK2 (death-associated protein
kinase 2) (Table 1). We speculate that putative free
DAP3 binds to free ERAL1 in mitochondria and the
two proteins work cooperatively for apoptosis and/or
other functions irrespective of the mitochondrial respira-
tory chain function. In this respect, it is noteworthy that
the replacement of glucose by galactose in the culture
medium did not augment the growth retardation
induced by the ERAL1 siRNA (Figure 8A)
Several mitochondrial ribosome-related genes are
known to be associated with mitochondrial disease and
diseases characterized by reduced energy metabolism.
For example, Weraarpachai et al. (42) have reported that
TACO1 protein is a translational activator of COX I.
Mutation of the TACO1 gene leads to cytochrome c
oxidase deﬁciency and resultantly to late onset Leigh
syndrome. The TACO1 protein is associated with
EF-Ts and involved speciﬁcally in the COX I synthesis.
LRPPRC (LRP130), which is a yeast translational acti-
vator of Pet309 (43), was coimmunoprecipitated with
ERAL1 (Table1). Pet309 is a mitochondrial protein
needed for the proper splicing and translational initiation
of mtDNA-encoded COX mRNA (43). These proteins
contain PPR motifs that consist of degenerate sequences
of 35 amino acids and form antiparallel a helices.
PPR motif proteins are thought to be involved in post-
translational mRNA metabolism, especially in
mitochondria and chloroplasts (44,45). Mutations
in LRPPRC are found in French–Canadian individuals
with Leigh syndrome harbouring an isolated COX deﬁ-
ciency (46). LRPPRC is reported to be involved in the
stabilization of mRNAs for both COX I and COX III in
mammals, without directly aﬀecting their translation, sug-
gesting that this protein is involved in processing of the pri-
mary RNA unit or in stabilizing mature transcripts with a
very limited sequence selectivity (47). Mitochondrial ribo-
somal proteins and translation related proteins should be
considered as important candidates for mitochondrial
disease, especially when mtDNA mutations have been
ruled out (47). Mutation of ERAL1 also could be a
cause of some types of mitochondrial disease.
ERAL1 may be involved in diverse functions, such as
mitoribosome assembly, mitochondrial translation, mito-
chondrial transcription, proliferation, apoptosis and so
on, as a mitoribosome-associated protein and/or free
protein.
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